STAT+: FDA approves Roivant therapy for rare autoimmune disease
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.